Post

In February, Rolling Stone reported on irregularities in Guinea-Bissau’s ethics review of the grant. The CDC’s former chief medical officer, Dr. Debra Houry, told us it’s “unfathomable that the CDC’s name is even implicated in this.” More ↓ www.rollingstone.com/politics/pol...

rollingstone.comNew Documents Reveal a Controversial Vaccine Study's Unusual Path to CDC ApprovalA new investigation has found irregularities in the ethics review of a grant to study effects of a birth dose of hepatitis B vaccine in Guinea-Bissau.

Earlier this month, Rolling Stone broke the news that the CDC decided to move forward with the previously shelved study, setting aside $1.6 million to help fund it with money directed by Congress for CDC global health security programs. More ↓ www.rollingstone.com/politics/pol...

rollingstone.comCDC Is Moving Forward With a Previously Shelved Controversial Hepatitis B Vaccine Study“It’s a wholly unethical trial, and it shouldn’t be allowed,” says Dr. Paul Offit of Guinea-Bissau study

And last week, we reported on how expiring funds had driven the rush to advance the study, in spite of the swirl of global criticism. WHO told us that regardless of revisions to the protocol, "The study is unethical.” More ↓ www.rollingstone.com/politics/pol...

rollingstone.comHow a Controversial Hepatitis B Study Was Funded by the CDC Amid a Global Swirl of CriticismAs experts questioned the ethics of the study, documents show that expiring funds forced a rushed vote in Denmark, where the researchers’ institute is based